FemiPro

What the vendor page documents

FemiPro is a capsule supplement marketed for bladder control, urinary microbiome balance and a "natural bladder-rebalancing breakthrough." The current offer page names five ingredients: mimosa pudica, bearberry, cranberry extract, granular berberine and a probiotic blend — and it now names the five strains: Lactobacillus crispatus, L. acidophilus, L. plantarum, L. gasseri and L. casei. They are presented as a proprietary blend, so the amount of each ingredient and the CFU count of the probiotics are not published. The same formula is sold under two brand names on sister pages; our catalog keeps one product page.

The routine is one capsule daily with plenty of water. The single bottle is $79; the page sells a two-bottle basic pack, a three-bottle pack and a six-bottle pack, with free shipping on the larger options. The vendor states a 60-day money-back guarantee and displays an aggregate of 19,263 reviews. Individual reviews with names, dates and full text are not published in the captured text version, so the aggregate is a vendor claim rather than an audited sample.

The page is written for women dealing with sudden urinary leaks and bladder-control worries. It says the formula targets harmful bacteria that overstimulate bladder muscles and promotes beneficial bacteria in the urinary microbiome.

What the page claims — and what it does not prove

The marketing says FemiPro supports bladder control by rebalancing the urinary microbiome. That is a plausible-sounding mechanism, but the page does not link a clinical trial of the finished formula, does not publish CFU counts for the named probiotic strains, and does not publish per-ingredient doses. Without those details, the microbiome claim cannot be evaluated.

Urinary leakage has several causes: pelvic-floor weakness, childbirth, menopause, prostate treatment in men, urinary tract infection, overactive bladder, neurological conditions and medication. A supplement cannot diagnose which one applies. If leakage is sudden, painful, bloody or accompanied by fever, it needs medical assessment — not a capsule.

The 19,263-review aggregate is a vendor figure. It might reflect real customers, but without individual reviews, a response rate or a moderation policy, it should be read as marketing. It is not an independent rating.

What the ingredients are studied for

• Mimosa pudica is a traditional herb used in some countries for intestinal and urinary complaints. Modern human trials are very limited.
• Bearberry (uva ursi) contains arbutin and is traditionally used for urinary-tract complaints. It is not a proven treatment for bladder leakage, and long-term use needs caution.
• Cranberry extract has modest evidence for preventing recurrent urinary tract infections in some women. It does not treat leakage or overactive bladder.
• Probiotic blend may support vaginal and urinary microbiome balance, but evidence is strain-specific. The strains are now named, but without CFU counts the dose cannot be assessed.
• Granular berberine has antimicrobial and glucose-lowering research. It can interact with medication and is not an established bladder treatment.

In short, the formula combines traditional urinary herbs, cranberry and probiotics. Some ingredients have plausible preventive roles; none is a proven cure for bladder leakage.

The newly named strains are a meaningful disclosure improvement. Lactobacillus crispatus is the dominant species in a healthy vaginal microbiome and has been studied for colonisation after oral and vaginal use; L. gasseri and L. plantarum appear in smaller urinary-health studies. The evidence is strain- and dose-specific, and oral probiotics do not reliably colonise the vagina, which is why the missing CFU count still matters. Naming the strains is a first step, not proof that this capsule changes the microbiome.

Safety and who should be cautious

• Urinary tract infection: fever, burning, blood in urine, flank pain or sudden worsening needs a doctor; do not self-treat with a supplement.
• Bearberry: long-term or high-dose use is not recommended; it can cause digestive upset and is not for pregnancy or kidney disease.
• Berberine: can interact with diabetes medication, blood-pressure drugs and some antibiotics; it can cause digestive upset and is not for pregnancy.
• Probiotics: caution in severe immunosuppression or with a central line.
• Pregnancy and breastfeeding: not established as safe; ask a professional.
• Kidney disease: review all herbs and supplements with a clinician.
• Surgery: disclose supplements before surgery.
• Allergies: plant extracts and cranberry can trigger reactions.

The 60-day refund window is a commercial term. Read our refund policy guide and confirm the return process before ordering.

Who it may suit — and who it does not

FemiPro may suit an adult woman with mild bladder-control concerns who has already discussed them with a clinician, understands that the evidence is limited, wants a cranberry-probiotic capsule and values a 60-day refund window. It is a poor fit for anyone with a suspected infection, blood in urine, severe or sudden leakage, pregnancy, kidney disease, or an expectation that capsules will replace pelvic-floor exercises or medical treatment.

Our new Women's Health category tracks what we cover in this niche. The comparison tool only pairs products from the same category, and the legitimacy check summarises the red flags.

What to check before buying

• Ask for the CFU count; the page names the strains but not the dose.
• Ask for per-ingredient amounts in the proprietary blend.
• Confirm the 60-day refund terms, including opened bottles and return shipping.
• Review bearberry and berberine interactions with a pharmacist, especially if you take diabetes or blood-pressure medication.
• See a clinician for persistent leakage; pelvic-floor physiotherapy is often more effective than supplements.

How the score treats this product

The score rewards the published single-bottle price, the 60-day refund window, the five named ingredients and the capture date. It does not award evidence points for unpublished doses, missing CFU counts or a formula without a product-specific trial. The "bladder-rebalancing breakthrough" framing is recorded as an exaggerated-claims red flag. That is a comment on disclosure and marketing, not a claim that the product cannot help anyone.

Sources

• FemiPro official text page (captured 2026-11-07)
• NCCIH — Probiotics: What You Need To Know
• NCCIH — Cranberry
• NIDDK — Bladder Control Problems
• MedlinePlus — Urinary Incontinence

Editorial content by the ViaReviews Research Team, last reviewed 2026-11-07. Informational only, not medical advice.